Literature DB >> 9058801

Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins.

S V Peña1, D A Hanson, B A Carr, T J Goralski, A M Krensky.   

Abstract

CTL and NK cells share a common cytolytic mechanism that involves regulated exocytosis of lytic molecules stored within cytoplasmic granules. Here we describe the processing, subcellular localization, and function of a T and NK cell-specific granule protein that shares homology with small, lytic granule-associated molecules. The gene coding for this protein, 519, is expressed late after T cell activation. Antisera raised against a 519/glutathione-S-transferase fusion protein and a series of peptides derived from the 519 protein sequence permitted the identification of two small CTL protein products of 15 and 9 kDa that are exocytosed after stimulation through the TCR. The 9-kDa product is a processed form of 519 and differs from the 15-kDa product in both its amino and carboxyl terminus. While both 519 proteins are found in cytoplasmic granules, the 9-kDa form is also present in dense, highly cytolytic granules. Functional studies indicate that this protein is lytic against tumor cell targets. The cell type- and stage-specific expression pattern of 519 along with its subcellular localization are reminiscent of molecules that play a vital role in granule-mediated cytolysis by CTL and NK cells. Its lytic activity suggests the involvement of 519 in CTL effector function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability.

Authors:  J S Passmore; R H Glashoff; P T Lukey; S R Ress
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis.

Authors:  Heike Bruhn; Beate Riekens; Otto Berninghausen; Matthias Leippe
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

4.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

5.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

6.  Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin.

Authors:  Qing Li; Chen Dong; Anmei Deng; Masao Katsumata; Ari Nakadai; Tomoyuki Kawada; Satoshi Okada; Carol Clayberger; Alan M Krensky
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.

Authors:  M Andersson; R Girard; P Cazenave
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 8.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

9.  Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.

Authors:  Yoko Kita; Satomi Hashimoto; Toshihiro Nakajima; Hitoshi Nakatani; Shiho Nishimatsu; Yasuko Nishida; Noriko Kanamaru; Yasuhumi Kaneda; Yasushi Takamori; David McMurray; Esterlina V Tan; Marjorie L Cang; Paul Saunderson; E C Dela Cruz; Masaji Okada
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

10.  Enrichment and analysis of secretory lysosomes from lymphocyte populations.

Authors:  Hendrik Schmidt; Christoph Gelhaus; Ralph Lucius; Melanie Nebendahl; Matthias Leippe; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-07-29       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.